EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Treatment of Epidermolysis Bullosa and Future Directions: A Review

Sorina Danescu, Mircea Negrutiu, Cristina Has

Dermatology and Therapy · 2024-08 · 14 (8) · 2059-2075

DOI: 10.1007/s13555-024-01227-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatology and Therapy, online erschienen am 02.08.2024. Verfasst von Sorina Danescu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Medicine Iuliu Hatieganu Cluj-Napoca, Cluj-Napoca, Romania. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidermolysis bullosa (EB) comprises rare genetic disorders characterized by skin and mucosal membrane blistering induced by mechanical trauma. Molecularly, pathogenic variants affect genes encoding proteins crucial for epidermal-dermal adhesion and stability. Management of severe EB is multidisciplinary, focusing on wound healing support, ensuring that patients thrive, and complication treatment. Despite extensive research over 30 years, novel therapeutic approaches face challenges. Gene therapy and protein therapy struggle with efficacy, while regenerative cell-based therapies show limited effects. Drug repurposing to target various pathogenic mechanisms has gained attention, as has in vivo gene therapy with drugs for dystrophic and junctional EB that were recently approved by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA). However, their high cost limits global accessibility. This review examines therapeutic advancements made over the past 5 years, exploiting a systematic literature review and clinical trial data.

Schlagwörter

Stichwörter der Autor:innen

BlisteringGene therapyRepurposed drugsSkin adhesionWound healing

Autor:innen und Institutionen

  • Department of Dermatology, University of Medicine Iuliu Hatieganu Cluj-Napoca, Cluj-Napoca, Romania.
  • Department of Dermatology, Medical Center University of Freiburg, Freiburg im Breisgau, Germany. cristina.has@uniklinik-freiburg.de.

Zitieren

APA

Danescu, S., Negrutiu, M., & Has, C. (2024). Treatment of Epidermolysis Bullosa and Future Directions: A Review. Dermatology and Therapy, 14(8), 2059-2075. https://doi.org/10.1007/s13555-024-01227-8

Vancouver

Danescu S, Negrutiu M, Has C. Treatment of Epidermolysis Bullosa and Future Directions: A Review. Dermatology and Therapy. 2024;14(8):2059-2075. doi:10.1007/s13555-024-01227-8

BibTeX
@article{Danescu2024,
  author = {Danescu, Sorina and Negrutiu, Mircea and Has, Cristina},
  title = {Treatment of Epidermolysis Bullosa and Future Directions: A Review},
  journal = {Dermatology and Therapy},
  year = {2024},
  volume = {14},
  number = {8},
  pages = {2059--2075},
  doi = {10.1007/s13555-024-01227-8}
}
Kostenlos starten →